New insider activity at CME Group ( (CME) ) has taken place on February 9, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Director Dennis Suskind has trimmed his position in CME Group, selling 748 shares of the company’s stock in a transaction valued at $224,400. This insider move highlights ongoing activity in CME Group’s executive ranks and may draw attention from investors tracking leadership confidence and trading behavior within the firm.
Recent Updates on CME stock
CME Group’s stock action over the last day has been driven by a strong Q4 and full‑year print showing record volumes, solid revenue and EPS growth, and industry‑leading margins, plus expanding high‑margin data and crypto businesses. An analyst also raised their stance and target after reassessing positioning into Q4, citing a desire to add exposure to volatility via CME’s franchise rather than any company‑specific setback.
Spark’s Take on CME Stock
According to Spark, TipRanks’ AI Analyst, CME is a Outperform.
The score is driven primarily by strong financial performance (high margins and low leverage) and a constructive earnings outlook supported by record activity, pricing actions, and capital returns. Offsetting factors are a relatively high valuation and technically overbought momentum signals that raise near-term volatility/pullback risk.
To see Spark’s full report on CME stock, click here.
More about CME Group
YTD Price Performance: 10.69%
Average Trading Volume: 1,989,279
Technical Sentiment Signal: Buy
Current Market Cap: $109B